➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
McKesson
Colorcon
Merck
Dow

Last Updated: October 24, 2020

DrugPatentWatch Database Preview

Details for Patent: 8,273,876

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,273,876 protect, and when does it expire?

Patent 8,273,876 protects LEVITRA and is included in one NDA.

This patent has fifty-four patent family members in thirty-one countries.

Summary for Patent: 8,273,876
Title:Medicaments containing vardenafil hydrochloride trihydrate
Abstract: The invention relates to a method for producing medicaments that contain vardenafil hydrochloride, essentially as trihydrate in solid form, and to medicaments that can be obtained according to this method.
Inventor(s): Serno; Peter (Gladbach, DE), Grunenberg; Alfons (Dormagen, DE), Ohm; Andreas (Neuss, DE), Bellinghausen; Rainer (Odenthal, DE), Vollers; Eimer (Leverkusen, DE), Henck; Jan-Olav (Leverkusen, DE)
Assignee: Bayer Intellectual Property GmbH (Monheim, DE)
Application Number:10/521,534
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 8,273,876

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Hlthcare LEVITRA vardenafil hydrochloride TABLET;ORAL 021400-003 Aug 19, 2003 DISCN Yes No   Start Trial   Start Trial TREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET   Start Trial
Bayer Hlthcare LEVITRA vardenafil hydrochloride TABLET;ORAL 021400-001 Aug 19, 2003 AB RX Yes No   Start Trial   Start Trial TREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET   Start Trial
Bayer Hlthcare LEVITRA vardenafil hydrochloride TABLET;ORAL 021400-002 Aug 19, 2003 AB RX Yes No   Start Trial   Start Trial TREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,273,876

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany102 32 113Jul 16, 2002
PCT Information
PCT FiledJuly 03, 2003PCT Application Number:PCT/EP03/07093
PCT Publication Date:January 22, 2004PCT Publication Number: WO2004/006894

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Dow
McKesson
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.